Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RESMED INC.

(RMD)
  Report
Delayed Quote. Delayed Nyse - 09/21 04:10:00 pm
288.23 USD   +1.41%
09/16INSIDER SELL : ResMed
MT
09/13INSIDER SELL : Resmed
MT
09/13RESMED : As Approved and Adopted by Board Resolution (Form 8-K)
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ResMed : RBC Raises Price Target on ResMed to $238 From $223, Citing Positive Implications From Philips; Underperform Maintained

07/27/2021 | 08:52am EDT


ę MT Newswires 2021
All news about RESMED INC.
09/16INSIDER SELL : ResMed
MT
09/13INSIDER SELL : Resmed
MT
09/13RESMED : As Approved and Adopted by Board Resolution (Form 8-K)
PU
09/13RESMED INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial St..
AQ
09/09RESMED : Oppenheimer Adjusts ResMed PT to $312 From $300, Maintains Outperform Rating
MT
09/08RESMED : Virtual Investor Day
PU
09/08RESMED : Announces Participation in the Bank of America Global Healthcare Conference
AQ
09/08RESMED : People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Suppor..
AQ
09/07INSIDER SELL : Resmed
MT
09/03INSIDER SELL : Resmed
MT
More news
Analyst Recommendations on RESMED INC.
More recommendations
Financials (USD)
Sales 2022 3 800 M - -
Net income 2022 869 M - -
Net cash 2022 77,0 M - -
P/E ratio 2022 49,0x
Yield 2022 0,65%
Capitalization 41 995 M 41 995 M -
EV / Sales 2022 11,0x
EV / Sales 2023 10,3x
Nbr of Employees 7 970
Free-Float 77,1%
Chart RESMED INC.
Duration : Period :
ResMed Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESMED INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 288,23 $
Average target price 260,00 $
Spread / Average Target -9,79%
EPS Revisions
Managers and Directors
Michael J. Farrell Chief Executive Officer & Director
Robert Andrew Douglas President & Chief Operating Officer
Brett A. Sandercock Chief Financial Officer
Peter C. Farrell Non-Executive Chairman
Carlos M. Nunez Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
RESMED INC.35.60%41 412
THERMO FISHER SCIENTIFIC28.13%232 196
DANAHER CORPORATION46.09%231 382
INTUITIVE SURGICAL, INC.23.94%120 655
SIEMENS HEALTHINEERS AG39.50%77 136
EDWARDS LIFESCIENCES CORPORATION30.90%73 546